Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?
Tomljenovic L, Spinosa JP, Shaw CA. Tomljenovic L, et al. Curr Pharm Des. 2013;19(8):1466-87. Curr Pharm Des. 2013. PMID: 23016780 Review.
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.
Inbar R, Weiss R, Tomljenovic L, Arango MT, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y. Inbar R, et al. Among authors: tomljenovic l. Immunol Res. 2017 Feb;65(1):136-149. doi: 10.1007/s12026-016-8826-6. Immunol Res. 2017. PMID: 27421722
WITHDRAWN: Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.
Inbar R, Weiss R, Tomljenovic L, Arango MT, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y. Inbar R, et al. Among authors: tomljenovic l. Vaccine. 2016 Jan 9:S0264-410X(16)00016-5. doi: 10.1016/j.vaccine.2015.12.067. Online ahead of print. Vaccine. 2016. PMID: 26778424
HPV vaccines and cancer prevention, science versus activism.
Tomljenovic L, Wilyman J, Vanamee E, Bark T, Shaw CA. Tomljenovic L, et al. Infect Agent Cancer. 2013 Feb 1;8(1):6. doi: 10.1186/1750-9378-8-6. Infect Agent Cancer. 2013. PMID: 23369430 Free PMC article.
Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?
Shaw CA, Li D, Tomljenovic L. Shaw CA, et al. Among authors: tomljenovic l. Immunotherapy. 2014;6(10):1055-71. doi: 10.2217/imt.14.81. Immunotherapy. 2014. PMID: 25428645 Review.
Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil.
Tomljenovic L, Shaw CA. Tomljenovic L, et al. J Law Med Ethics. 2012 Fall;40(3):673-81. doi: 10.1111/j.1748-720X.2012.00698.x. J Law Med Ethics. 2012. PMID: 23061593
Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?
Tomljenovic L, Shaw CA. Tomljenovic L, et al. Ann Med. 2013 Mar;45(2):182-93. doi: 10.3109/07853890.2011.645353. Epub 2011 Dec 22. Ann Med. 2013. PMID: 22188159 Review.
Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.
Shaw CA, Tomljenovic L. Shaw CA, et al. Among authors: tomljenovic l. Immunol Res. 2013 Jul;56(2-3):304-16. doi: 10.1007/s12026-013-8403-1. Immunol Res. 2013. PMID: 23609067 Review.
Aluminum vaccine adjuvants: are they safe?
Tomljenovic L, Shaw CA. Tomljenovic L, et al. Curr Med Chem. 2011;18(17):2630-7. doi: 10.2174/092986711795933740. Curr Med Chem. 2011. PMID: 21568886
Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.
Tomljenovic L, Shaw CA. Tomljenovic L, et al. Lupus. 2012 Feb;21(2):223-30. doi: 10.1177/0961203311430221. Lupus. 2012. PMID: 22235057
30 results
Jump to page
Feedback